Allogeneic Vγ9Vδ2 T cells

V gamma 9 V delta 2 T cells · Beijing Tiantan Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic Vγ9Vδ2 T cells, covering 2024-05-02 to 2024-05-02. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma [EARLY_Phase 1]